The Myelin Repair Foundation has a single, narrow focus: Discover and develop myelin repair treatments to improve the lives of people suffering from multiple sclerosis (MS). To do this, MRF harnesses and channels the talents of five of the world’s leading neuroscientists approaching the study of myelin from five different perspectives — immunology, genetics, developmental biology, molecular biology and proteomics — in an outcome-driven research plan.
Accelerating Research Progress
MRF provides the funding, collaborative process strategy, technology and management that enable the scientists to focus their energies on science and not administration. For complex diseases like multiple sclerosis, this unique business/science model significantly accelerates the process of drug discovery.
Since the MRF research team began its research in July of 2004, our rate of progress and the results achieved are unparalleled. Our accomplishments include the following:
- More than a dozen novel myelin repair targets have been identified.
- Eight patents have been filed by MRF on these discoveries.
- Ten research tools have been developed in order to accomplish these important discoveries. Six of these tools may lead to additional patents.
Formula for Success
The Myelin Repair Foundation has brought together an aggressive plan with the right scientific team. The result: We're speeding the time it takes to develop and move scientific discoveries from the laboratory to the MS patient -- making the process up to 100% faster.
